Ten years after President Clinton hailed the completion of the first draft of the human genome, on June 25, 2000, these doctors-to-be are grappling with the many challenges posed by a dawning era of genomic medicine.
The Presidential Commission for the Study of Bioethical Issues held its first meeting on July 8-9. David Rejeski testified on the ethical issues of synthetic biology.
The Synthetic Biology Project at the Woodrow Wilson Center is partnering with DIYbio.org, on a project to ensure safety within the rapidly expanding community of amateur biologists.
The Synthetic Biology Project found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, funded in large part by the Department of Energy.
SPLICE is a theatrical depiction of rebellious scientists manipulating DNA. Share your thoughts about the movie.
A couple of guys in a garage changed computer technology. Will someone in a basement one day transform biology just as radically? We explore the tantalizing — and maybe terrifying — frontier of synthetic biology and do-it-yourself life science.
David Rejeski discusses the ethics of creating synthetic life on NPR's All Things Considered.
For 15 years, J. Craig Venter has chased a dream: to build a genome from scratch and use it to make synthetic life. Now, he and his team at the J. Craig Venter Institute (JCVI) in Rockville, Maryland, and San Diego, California, say they have realized that dream.
Looking at safety as a priority, the feds reach out to members of a new movement that takes science into neighborhoods. This video features an interview with Synthetic Biology Project Director David Rejeski.
A new report defines the criteria for a new technology assessment function in the United States, emphasizing the need to incorporate citizen-participation methods to complement expert analysis.
The Pink Army Cooperative is selling $20 shares in a journey toward a personalized cure for breast cancer. This Canadian organization has set out to lower the cost of cancer treatments while also making them more effective by embracing a new wave of synthetic biology technology.
Darpa, in a move that means to use bioweapons for good, has announced the investment of $6 million into a project that will create "synthetic organisms" that never die but can be killed with the flick of a molecular switch.
The Synthetic Biology Project will be covering this year's International Genetically Engineered Machine competition at MIT. Stay tuned for nearly live video interviews with some of this year's contestants.